Codexis, Inc. (CDXS)
2.53
+0.01
(+0.40%)
USD |
NASDAQ |
Apr 24, 10:12
Codexis Shareholders Equity (Quarterly) : 50.53M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 52.61B |
| Incyte Corp. | 5.167B |
| Niagen Bioscience, Inc. | 76.53M |
| MacroGenics, Inc. | 55.59M |
| Viridian Therapeutics, Inc. | 722.17M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 147.80M |
| Total Liabilities (Quarterly) | 97.27M |
| Debt to Equity Ratio | 1.449 |
| Current Ratio | 3.824 |
| Net Debt Paydown Yield | -4.25% |